The Safety Of Two Intravenous Heparin Doses As Adjunct To PCI In ACS Patients Treated With Fondaparinux, Results From The FUTURA/OASIS 8 Trial

Links shared publicly online about this topic.

  • 905
    total visits

The Safety Of Two Intravenous Heparin Doses As Adjunct To PCI In ACS Patients Treated With Fondaparinux, Results From The FUTURA/OASIS 8 Trial

medicalnewstoday.com —

Results from the FUTURA/OASIS 8 study presented at the ESC Congress provide initial evidence that a low dose of unfractionated heparin does not reduce the incidence of bleeding or vascular complic

View full resource at medicalnewstoday.com

Tags: Bleeding, Safety

  • Share

Most Recently Shared on September 1, 2010 at 1:00 pm By:

mnt_vascular MNT Vascular

The Safety Of Two Intravenous Heparin Doses As Adjunct To PCI In ACS Patients Treated With Fondaparinux, Results From ... http://mnt.to/3J6j

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Blood MNT Blood

Advertisement